{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:49:11Z","timestamp":1791596951715,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013928","name":"Instituto Milenio en Inmunolog\u00eda e Inmunoterapia","doi-asserted-by":"publisher","award":["ICN2021_045"],"award-info":[{"award-number":["ICN2021_045"]}],"id":[{"id":"10.13039\/501100013928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013928","name":"Instituto Milenio en Inmunolog\u00eda e Inmunoterapia","doi-asserted-by":"publisher","award":["ICN09_016"],"award-info":[{"award-number":["ICN09_016"]}],"id":[{"id":"10.13039\/501100013928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013928","name":"Instituto Milenio en Inmunolog\u00eda e Inmunoterapia","doi-asserted-by":"publisher","award":["P09\/016-F"],"award-info":[{"award-number":["P09\/016-F"]}],"id":[{"id":"10.13039\/501100013928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["21221472"],"award-info":[{"award-number":["21221472"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["21251811"],"award-info":[{"award-number":["21251811"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["21210336"],"award-info":[{"award-number":["21210336"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.isci.2026.117131","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:27:49Z","timestamp":1788964069000},"page":"117131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term stability of the GMP-compliant recombinant BCG vaccine against human RSV under quality control analyses"],"prefix":"10.1016","volume":"29","author":[{"given":"Tays","family":"Troncoso-Bravo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela B.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A.","family":"Loaiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3651-564X","authenticated-orcid":false,"given":"Valentina","family":"Pavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3103-3708","authenticated-orcid":false,"given":"Drosos","family":"Kourounis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2918-0523","authenticated-orcid":false,"given":"Kyveli P.","family":"Tsatsara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Horefti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Martinez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Rabias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n F.","family":"Pe\u00f1aloza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-6870","authenticated-orcid":false,"given":"Pablo A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7622-5263","authenticated-orcid":false,"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117131_bib1","first-page":"101364","article-title":"A new era for RSV: the end in sight?","volume":"53","year":"2026","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.isci.2026.117131_bib2","first-page":"75","article-title":"Respiratory Syncytial Virus: Diagnosis, Treatment and Prevention","volume":"14","author":"Eiland","year":"2009","journal-title":"J. Pediatr. Pharmacol. Therapeut."},{"key":"10.1016\/j.isci.2026.117131_bib3","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.36342","article-title":"Respiratory Syncytial Virus: A Comprehensive Review of Transmission, Pathophysiology, and Manifestation","author":"Kaler","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.isci.2026.117131_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/rmv.1704","article-title":"Respiratory syncytial virus infection and immunity","volume":"22","author":"Gonz\u00e1lez","year":"2012","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.isci.2026.117131_bib5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0036-1584799","article-title":"Human Respiratory Syncytial Virus: Infection and Pathology","volume":"37","author":"Bohmwald","year":"2016","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2026.117131_bib6","series-title":"Viral Infections of Humans","first-page":"601","article-title":"Paramyxoviruses: Respiratory Syncytial Virus and Human Metapneumovirus","author":"Crowe","year":"2014"},{"key":"10.1016\/j.isci.2026.117131_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.664212","article-title":"A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus","volume":"12","author":"D\u00edaz","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117131_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100517","article-title":"Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial","volume":"27","author":"Abarca","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.isci.2026.117131_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.vaccine.2016.12.048","article-title":"A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice","volume":"35","author":"C\u00e9spedes","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2026.117131_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.662714","article-title":"Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice","volume":"11","author":"Soto","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.isci.2026.117131_bib11","doi-asserted-by":"crossref","first-page":"20822","DOI":"10.1073\/pnas.0806244105","article-title":"Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG","volume":"105","author":"Bueno","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.117131_bib12","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.3389\/fimmu.2018.02875","article-title":"Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity","volume":"9","author":"Soto","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117131_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1215893","article-title":"Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults","volume":"14","author":"Pacheco","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117131_bib14","year":"1995"},{"key":"10.1016\/j.isci.2026.117131_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.30895\/2221-996X-2024-24-2-229-236","article-title":"Recommendations for the development of sterility testing procedures for biological medicinal products based on pharmacopoeial methods","volume":"24","author":"Berdnikova","year":"2024","journal-title":"Biological Products. Prevention, Diagnosis, Treatment"},{"key":"10.1016\/j.isci.2026.117131_bib16","series-title":"A WHO guide to good manufacturing practice (GMP) requirements \/ written by Gillian Chaloner-Larsson, Roger Anderson, Anik Egan; in collaboration with Manoel Antonio da Fonseca Costa Filho, Jorge F. Gomez","author":"Chaloner-Larsson","year":"1999"},{"key":"10.1016\/j.isci.2026.117131_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/erv.09.23","article-title":"Reaching international GMP standards for vaccine production: challenges for developing countries","volume":"8","author":"Milstien","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.isci.2026.117131_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1021905","article-title":"Current GMP standards for the production of vaccines and antibodies: An overview","volume":"10","author":"Covarrubias","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.isci.2026.117131_bib19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117131_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.isci.2026.117131_bib21","series-title":"Temperature Sensitivity of Vaccines Immunization, Vaccines and Biologicals","year":"2006"},{"key":"10.1016\/j.isci.2026.117131_bib22","series-title":"WHO preferred Product Characteristics for Respiratory Syncytial Virus (RSV) Vaccines","year":"2017"},{"key":"10.1016\/j.isci.2026.117131_bib23","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117131_bib24","series-title":"The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","author":"Abraham","year":"2009"},{"key":"10.1016\/j.isci.2026.117131_bib25","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1099\/vir.0.2008\/004051-0","article-title":"Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation","volume":"89","author":"Derdowski","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.isci.2026.117131_bib26","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/v13122478","article-title":"Immunopathology of RSV: An Updated Review","volume":"13","author":"Bergeron","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.117131_bib27","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.4049\/jimmunol.0903452","article-title":"Efficient Lung Recruitment of Respiratory Syncytial Virus-Specific Th1 Cells Induced by Recombinant Bacillus Calmette-Gu\u00e9rin Promotes Virus Clearance and Protects from Infection","volume":"185","author":"Cautivo","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.117131_bib28","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3389\/fimmu.2020.01507","article-title":"Current Insights in the Development of Efficacious Vaccines Against RSV","volume":"11","author":"Soto","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117131_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molimm.2014.12.004","article-title":"Immunology of bovine respiratory syncytial virus in calves","volume":"66","author":"Guzman","year":"2015","journal-title":"Mol. Immunol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226025095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226025095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:52:51Z","timestamp":1791593571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226025095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589004226025095"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117131","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term stability of the GMP-compliant recombinant BCG vaccine against human RSV under quality control analyses","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117131"}}